More Globe Newswire

View Older Stories View Newer Stories

May 13, 2025 04:05PM Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025 04:05PM NeuroPace Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM SoundThinking, Inc. Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2025 04:05PM Viasat Sets May 20, 2025 for Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call and Webcast
May 13, 2025 04:05PM Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2025 Guidance
May 13, 2025 04:05PM Parsons Selected As Delivery Partner For King Salman International Airport
May 13, 2025 04:05PM Glass House Brands Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Spectral AI Announces 2025 First Quarter Financial Results
May 13, 2025 04:05PM Iridex Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
May 13, 2025 04:05PM Zevra Reports First Quarter 2025 Financial Results and Corporate Update
May 13, 2025 04:05PM NEXGEL Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update
May 13, 2025 04:05PM Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
May 13, 2025 04:05PM Hyperfine, Inc. Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM AGM Group Holdings Inc. Files 2024 Annual Report on Form 20-F
May 13, 2025 04:05PM Casella Waste Systems, Inc. to Present at Upcoming Investor Conferences
May 13, 2025 04:05PM MannKind to Present at Upcoming Investor Conferences
May 13, 2025 04:05PM Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
May 13, 2025 04:05PM Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
May 13, 2025 04:05PM Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 13, 2025 04:05PM Safe Bulkers, Inc. Sets Date for the First Quarter 2025 Results, Conference Call, and Webcast
May 13, 2025 04:05PM Robinhood Markets, Inc. Reports April 2025 Operating Data
May 13, 2025 04:05PM DoubleDown Interactive Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025 04:05PM Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025
May 13, 2025 04:05PM WEBTOON Entertainment Inc. Reports First Quarter 2025 Financial Results
May 13, 2025 04:05PM Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th
May 13, 2025 04:05PM Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
May 13, 2025 04:05PM Energous Wireless Power Solutions Reports First Quarter 2025 Results
May 13, 2025 04:02PM IZEA Announces Intention to Commence a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock
May 13, 2025 04:01PM iCAD Reports Financial Results for First Quarter Ended March 31, 2025
May 13, 2025 04:01PM Vaxart Appoints Jeroen Grasman as Chief Financial Officer
May 13, 2025 04:01PM Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
May 13, 2025 04:01PM MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results
May 13, 2025 04:01PM Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
May 13, 2025 04:01PM IZEA Reports Q1 2025 Revenue from Core Operations of $8.0 million, up 23%
May 13, 2025 04:00PM Microvast at CIBF 2025: Powering What's Next
May 13, 2025 04:01PM Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
May 13, 2025 04:01PM Gevo Reports First Quarter 2025 Financial Results
May 13, 2025 04:01PM Olema Oncology Reports First Quarter 2025 Financial and Operating Results
May 13, 2025 04:01PM Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
May 13, 2025 04:01PM Biodesix Announces First Quarter 2025 Results and Highlights
May 13, 2025 04:01PM Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
May 13, 2025 04:01PM New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)
May 13, 2025 04:00PM Microvast at CIBF 2025: Powering What's Next
May 13, 2025 04:00PM Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
May 13, 2025 04:00PM Global Star Acquisition Inc. and K Enter Holdings Inc. Finalize Business Combination
May 13, 2025 04:00PM DeFi Development Corp. to Host X Spaces Event: “Fireside Chat with John Han (CFO), DK (Head of IR), and Pete Humiston (Head of Research and Content)”
View Newer Stories View Older Stories